Marshall Wace
ANAC

Marshall Wace’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Marshall Wace’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-40,161
Closed -$4.54M – 1362
2015
Q4 		$4.54M Sell
40,161
-53,248
-57% -$5.87M 0.04% 403
2015
Q3 		$11M Sell
93,409
-33,075
-26% -$4.32M 0.14% 166
2015
Q2 		$9.79M Sell
126,484
-141,991
-53% -$9.31M 0.13% 179
2015
Q1 		$15.5M Buy
268,475
+70,676
+36% +$3M 0.2% 138
2014
Q4 		$6.38M Sell
197,799
-91,463
-32% -$2.75M 0.08% 268
2014
Q3 		$7.08M Buy
289,262
+213,706
+283% +$4.34M 0.1% 234
2014
Q2 		$1.34M Buy
+75,556
New +$1.22M 0.02% 461

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Marshall Wace's ANAC Position: Q1 2016 in Review

Marshall Wace sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 40,161 shares — an estimated $4.54M sold.

Marshall Wace first reported a position in ANAC in Q2 2014 and held it in 7 quarters. The position peaked at $15.5M in Q1 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Marshall Wace reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Marshall Wace sold 40,161 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $4.54M.
  • Marshall Wace first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 7 quarters.
  • Marshall Wace's ANACOR PHARMACEUTICALS INC COM position peaked at $15.5M in Q1 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.